Cargando…
Quantitative Translation in Immuno‐Oncology Research and Development
Autores principales: | Bottino, Dean, Liu, Rachael, Bazzazi, Hojjat, Venkatakrishnan, Karthik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485139/ https://www.ncbi.nlm.nih.gov/pubmed/32645203 http://dx.doi.org/10.1002/cpt.1936 |
Ejemplares similares
-
Lights and Shadows in Immuno-Oncology Drug Development
por: Bergamino Sirvén, Milana, et al.
Publicado: (2021) -
Advancing translational research for colorectal immuno-oncology
por: Thomas, Elaine M., et al.
Publicado: (2023) -
Translational Research in Oncology: Implications for Palliative Care
por: Ghoshal, Arunangshu
Publicado: (2017) -
Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology
por: Reinherz, Ellis L., et al.
Publicado: (2023) -
Diversity and Inclusion in Drug Development: Rethinking Intrinsic and Extrinsic Factors with Patient Centricity
por: Venkatakrishnan, Karthik, et al.
Publicado: (2021)